A Pill Everyone Can Swallow
The FDA’s proposal to modernize generic drug approvals meets with broad support.
Senators Introduce Bipartisan Bill to Streamline Medical Device Approval
New bill would allow manufacturers of certain medical device to bypass elements of FDA’s existing process.
An Incomplete Contraceptive Coverage Compromise
Despite political assurances, nothing has changed legally in the contraceptive insurance controversy.
FDA Submits User-Fee Recommendations to Congress
Agency recommends statutory language for imposing user fees on biosimilar drug manufacturers.
FDA Warns Patients of Stem Cell Scams
The FDA cautions patients to undergo only approved stem cell treatments.
Regulatory Conference Discusses Oversight of Laboratory Developed Tests
Regulatory conference highlights need for defined governance of laboratory developed diagnostic testing.
USDA Proposes to Modernize Poultry Slaughter Inspection
The USDA would inspect operations while decreasing its focus on expensive slaughter line inspections.
HHS Finds Proposed Health Insurance Rate Increases “Unreasonable”
Affordable Care Act requires approval of insurance company rate hikes for individual and small group plans.
The Value of Codifying a National Approach to Licensing Military-Affiliated Health Care Providers
Statutory change will ease medical training and health care delivery by the Department of Defense.
Over-Regulation of Parthenotes Stifles Valuable Scientific Research
Federal government should fund research using stem cells from unfertilized eggs.
Reclaiming Workplace Health and Safety for All
Inconsistent enforcement of the UK’s health and safety regulations unduly burdens businesses.